Dual Targeting of MAPK and PI3K Pathways Unlocks Redifferentiation of Braf-Mutated Thyroid Cancer Organoids

Using mESC-derived thyroid organoids, researchers developed a BrafV637E-inducible model able to recapitulate the features of papillary thyroid cancer in vitro.